Oral Sildenafil for Exercise Capacity, Dyspnea and Cardiopulmonary Function in COPD
Oral Sildenafil for Exercise Capacity, Dyspnea and Cardiopulmonary Function in COPD
Recruiting · NCT05061368 · Registry updated 2026-07-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Oral Sildenafil for Exercise Capacity, Dyspnea and Cardiopulmonary Function in COPD | Chronic Disease, Disease Attributes, Dyspnea, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Respiration Disorders, Signs and Symptoms, Signs and Symptoms, Respiratory, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, respiratory system disorder | Recruiting | Phase 2 | 2026-07-08 | NCT05061368 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Canadian Institutes of Health Research (CIHR) | 339 |
| University of Alberta | 249 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Clinical Physiology Laboratory | Edmonton | Canada | 4 |